1991
DOI: 10.1016/0020-711x(91)90176-n
|View full text |Cite
|
Sign up to set email alerts
|

Interaction of cremophor el with human plasma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
21
0

Year Published

1995
1995
2016
2016

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 66 publications
(21 citation statements)
references
References 19 publications
0
21
0
Order By: Relevance
“…The mechanisms underlying this effect are not apparent, although they are probably related to the modality of interaction between the individual 60- lipoprotein classes and the lipophilic vehicle. Thus, Cremophor has been found to alter the density of lipoproteins (Kongshaug et al, 1991), indicating that at least a partial fusion between the oil emulsion and the lipid moiety of the phospholipid bilayer of the lipoproteins must occur. Similarly, the fluidity and composition of the phospholipid bilayer of liposomal vesicles influences both the interlipoprotein distribution of phthalocyanines and the kinetics of photosensitiser release to lipoproteins (L Polo, E Reddi and G Jori, unpublished observations).…”
Section: Discussionmentioning
confidence: 99%
“…The mechanisms underlying this effect are not apparent, although they are probably related to the modality of interaction between the individual 60- lipoprotein classes and the lipophilic vehicle. Thus, Cremophor has been found to alter the density of lipoproteins (Kongshaug et al, 1991), indicating that at least a partial fusion between the oil emulsion and the lipid moiety of the phospholipid bilayer of the lipoproteins must occur. Similarly, the fluidity and composition of the phospholipid bilayer of liposomal vesicles influences both the interlipoprotein distribution of phthalocyanines and the kinetics of photosensitiser release to lipoproteins (L Polo, E Reddi and G Jori, unpublished observations).…”
Section: Discussionmentioning
confidence: 99%
“…In TaxolÂź, the first paclitaxel formulation used in clinical practice, paclitaxel, is solubilised by a surfactant in an organic medium, CremophorÂźEL (polyethoxylated castor oil), and dehydrated ethanol in a 1:1 (vol/vol) ratio. CremophorÂźEL is an excipient with notorious effects on humans, such as life-threatening anaphylaxis (4)(5)(6), hyperlipidaemia (7), abnormal lipoprotein patterns (8,9), the aggregation of erythrocytes (10), and peripheral neuropathy (11)(12)(13). Some studies indicate that CremophorÂźEL may trigger complement activation (14)(15)(16).…”
Section: Introductionmentioning
confidence: 98%
“…Recently, we have observed that the selectivity and efficiency of phthalocyanine accumulation in the MS-2 fibrosarcoma increases with an increasing degree of hydrophobicity of the dye and the extent of phthalocyanine associated with serum LDL (Soncin et al, 1995a). In particular, Cremophor appears to promote a greater selectivity of tumour targeting by a given phthalocyanine compared with liposomal vesicles (Soncin et al, 1995b), since it determines a larger release of the incorporated photosensitiser to LDL, probably owing to a specific interaction leading to an alteration of this component of the lipoprotein family (Kongshaug et al, 1991;Woodburn et al, 1994). On these bases, the extremely high selectivity of ZnODPc uptake in the tumour can be related to its unusually high affinity for LDL, which is clearly expressed by the data on the distribution of this phthalocyanine among serum proteins (see Table I).…”
Section: Discussionmentioning
confidence: 99%